205 related articles for article (PubMed ID: 12023422)
1. Anti-GT1a IgG in Guillain-Barré syndrome.
Koga M; Yoshino H; Morimatsu M; Yuki N
J Neurol Neurosurg Psychiatry; 2002 Jun; 72(6):767-71. PubMed ID: 12023422
[TBL] [Abstract][Full Text] [Related]
2. Antiganglioside antibody in patients with Guillain-Barré syndrome who show bulbar palsy as an initial symptom.
Koga M; Yuki N; Hirata K
J Neurol Neurosurg Psychiatry; 1999 Apr; 66(4):513-6. PubMed ID: 10201426
[TBL] [Abstract][Full Text] [Related]
3. Is IgG anti-GT1a antibody associated with pharyngeal-cervical-brachial weakness or oropharyngeal palsy in Guillain-Barré syndrome?
Koga M; Yuki N; Ariga T; Morimatsu M; Hirata K
J Neuroimmunol; 1998 Jun; 86(1):74-9. PubMed ID: 9655474
[TBL] [Abstract][Full Text] [Related]
4. [A case with upper limb dominant Guillain-Barré syndrome and serum IgG anti-GT1a antibodies: sparing oropharyngeal palsy].
Ogawa K; Hoshino H; Takagi M; Mizoi Y; Irie S; Saito T
Rinsho Shinkeigaku; 2001 Oct; 41(10):679-82. PubMed ID: 11993188
[TBL] [Abstract][Full Text] [Related]
5. Anti-GQ1b antibody syndrome: anti-ganglioside complex reactivity determines clinical spectrum.
Fukami Y; Wong AH; Funakoshi K; Safri AY; Shahrizaila N; Yuki N
Eur J Neurol; 2016 Feb; 23(2):320-6. PubMed ID: 26176883
[TBL] [Abstract][Full Text] [Related]
6. Antibodies to GT1a ganglioside in patients with Guillain-Barré syndrome.
Ilyas AA; Cook SD; Mithen FA; Taki T; Kasama T; Handa S; Hamasaki H; Singhal BS; Li SC; Li YT
J Neuroimmunol; 1998 Mar; 82(2):160-7. PubMed ID: 9585812
[TBL] [Abstract][Full Text] [Related]
7. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
[TBL] [Abstract][Full Text] [Related]
8. Antibodies to ganglioside complexes consisting of asialo-GM1 and GQ1b or GT1a in Fisher and Guillain-Barré syndromes.
Ogawa G; Kaida K; Kusunoki S; Ueda M; Kimura F; Kamakura K
J Neuroimmunol; 2009 Sep; 214(1-2):125-7. PubMed ID: 19631994
[TBL] [Abstract][Full Text] [Related]
9. Range of cross reactivity of anti-GM1 IgG antibody in Guillain-Barré syndrome.
Koga M; Tatsumoto M; Yuki N; Hirata K
J Neurol Neurosurg Psychiatry; 2001 Jul; 71(1):123-4. PubMed ID: 11413278
[TBL] [Abstract][Full Text] [Related]
10. Prospective study on anti-ganglioside antibodies in childhood Guillain-Barré syndrome.
Schessl J; Koga M; Funakoshi K; Kirschner J; Muellges W; Weishaupt A; Gold R; Korinthenberg R
Arch Dis Child; 2007 Jan; 92(1):48-52. PubMed ID: 16920757
[TBL] [Abstract][Full Text] [Related]
11. Clinical correlates of serum anti-GT1a IgG antibodies.
Nagashima T; Koga M; Odaka M; Hirata K; Yuki N
J Neurol Sci; 2004 Apr; 219(1-2):139-45. PubMed ID: 15050449
[TBL] [Abstract][Full Text] [Related]
12. Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies.
Chiba A; Kusunoki S; Obata H; Machinami R; Kanazawa I
Neurology; 1993 Oct; 43(10):1911-7. PubMed ID: 8413947
[TBL] [Abstract][Full Text] [Related]
13. [A case of Guillain-Barré syndrome with bulbar palsy and a high titer of anti-GT1a antibody].
Hashiguchi S; Ogasawara N; Yoshino H
Rinsho Shinkeigaku; 1997 Apr; 37(4):331-3. PubMed ID: 9248344
[TBL] [Abstract][Full Text] [Related]
14. Fulminant Guillain-Barré syndrome after Campylobacter jejuni enteritis and monospecific anti-GT1a IgG antibody.
Okuda B; Koga M; Katsuta T; Okamoto K; Yuki N
Intern Med; 2002 Oct; 41(10):889-91. PubMed ID: 12413017
[TBL] [Abstract][Full Text] [Related]
15. Ganglioside complexes containing GQ1b as targets in Miller Fisher and Guillain-Barre syndromes.
Kanzaki M; Kaida K; Ueda M; Morita D; Hirakawa M; Motoyoshi K; Kamakura K; Kusunoki S
J Neurol Neurosurg Psychiatry; 2008 Oct; 79(10):1148-52. PubMed ID: 18339728
[TBL] [Abstract][Full Text] [Related]
16. Fulminant Guillain-Barré syndrome showing severe pharyngeal-cervical-brachial weakness in the recovery phase: a case report.
Nakamura Y; Motoki M; Hirose T; Hosokawa T; Ishida S; Arawaka S
BMC Neurol; 2019 Jun; 19(1):145. PubMed ID: 31253118
[TBL] [Abstract][Full Text] [Related]
17. GM1/GalNAc-GD1a complex: a target for pure motor Guillain-Barre syndrome.
Kaida K; Sonoo M; Ogawa G; Kamakura K; Ueda-Sada M; Arita M; Motoyoshi K; Kusunoki S
Neurology; 2008 Nov; 71(21):1683-90. PubMed ID: 19015484
[TBL] [Abstract][Full Text] [Related]
18. Association of antibodies to ganglioside complexes and conduction blocks in axonal Guillain-Barré syndrome presenting as acute motor conduction block neuropathy.
Créange A; Shahrizaila N; Salhi H; Lefaucheur JP; Yuki N
J Peripher Nerv Syst; 2014 Jun; 19(2):115-20. PubMed ID: 24750296
[TBL] [Abstract][Full Text] [Related]
19. GD1b-specific antibody induces ataxia in Guillain-Barre syndrome.
Kaida K; Kamakura K; Ogawa G; Ueda M; Motoyoshi K; Arita M; Kusunoki S
Neurology; 2008 Jul; 71(3):196-201. PubMed ID: 18625966
[TBL] [Abstract][Full Text] [Related]
20. IgG antiganglioside antibodies in Guillain-Barré syndrome with bulbar palsy.
Yoshino H; Harukawa H; Asano A
J Neuroimmunol; 2000 Jun; 105(2):195-201. PubMed ID: 10742563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
